Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Antihypertensive Drugs: Potassium-Sparing Diuretics01:28

Antihypertensive Drugs: Potassium-Sparing Diuretics

Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Randomized Controlled Trial of Intradialytic Cycling as Kidney Exercise Rehabilitation for Cardiac Stunning in Hemodialysis (TICKERS_HD): A Clinical Research Protocol.

Canadian journal of kidney health and disease·2026
Same author

Coronary Artery Disease and Intradialytic Myocardial Ischemia in Hemodialysis: An Exploratory Study Using Intradialytic Imaging.

Kidney medicine·2025
Same author

Impact of Expanded Hemodialysis on Subjective Experience Using Dynamic Patient-Reported Outcome Measurement Tool.

Kidney medicine·2025
Same author

Fluid Volume Estimation by Bioimpedance: Methodological Caveats and Clinical Interpretation.

American journal of nephrology·2025
Same author

The Effect of Dialysate Sodium on Endothelial Injury and Microcirculatory Dysfunction.

Kidney360·2025
Same author

<sup>23</sup>NaMRI Assessed Cyst Sodium Concentration in Polycystic Kidney Disease to Identify Cyst Metabolic Activity: A Proof of Concept Study.

Kidney medicine·2024

Related Experiment Video

Updated: Jun 22, 2026

Contractility Measurements on Isolated Papillary Muscles for the Investigation of Cardiac Inotropy in Mice
06:22

Contractility Measurements on Isolated Papillary Muscles for the Investigation of Cardiac Inotropy in Mice

Published on: September 17, 2015

Myocardial contractile function and intradialytic hypotension.

Paul J Owen1, William S Priestman, Mhairi K Sigrist

  • 1Department of Renal Medicine, Derby City General Hospital, Derby, United Kingdom.

Hemodialysis International. International Symposium on Home Hemodialysis
|May 28, 2009
PubMed
Summary

Hypotension-prone hemodialysis patients exhibit impaired cardiovascular responses to dobutamine-atropine stress, indicating reduced myocardial contractile reserve. Early identification can improve intradialytic tolerability and prevent myocardial injury.

Related Experiment Videos

Last Updated: Jun 22, 2026

Contractility Measurements on Isolated Papillary Muscles for the Investigation of Cardiac Inotropy in Mice
06:22

Contractility Measurements on Isolated Papillary Muscles for the Investigation of Cardiac Inotropy in Mice

Published on: September 17, 2015

Area of Science:

  • Nephrology
  • Cardiology
  • Physiology

Background:

  • Dialysis-induced hypotension is a major complication for hemodialysis patients.
  • Impaired blood pressure control and myocardial reserve contribute to intradialytic hypotension.
  • Episodic hypotension may worsen myocardial injury in hemodialysis patients.

Purpose of the Study:

  • To investigate cardiovascular functional responses to pharmacological stress in hypotension-prone (HP) versus hypotension-resistant (HR) hemodialysis patients.
  • To assess hemodynamic variables and baroreflex sensitivity during dobutamine-atropine stress (DAS).

Main Methods:

  • Pilot study of 10 matched chronic hemodialysis patients (5 HP, 5 HR).
  • Noninvasive pulse-wave analysis (Finometer) during dobutamine-atropine stress (DAS).
  • Measurement of hemodynamic variables and baroreflex sensitivity at rest and during DAS.

Main Results:

  • Hypotension-prone patients showed a significant decrease in mean arterial pressure during DAS (-13.6 mmHg).
  • HP patients failed to significantly increase cardiac output, unlike HR patients (+33.4%).
  • Higher mean baroreflex sensitivity was observed in HR compared to HP subjects during pharmacological stress.

Conclusions:

  • Hypotension-prone hemodialysis patients demonstrate an impaired cardiovascular response to dobutamine-atropine stress.
  • The primary abnormality in HP patients is reduced myocardial contractile reserve.
  • Early identification of HP patients could enable therapeutic strategies to improve intradialytic tolerability and mitigate myocardial injury.